| X24-05-ZQ405 |
Epigenetic reader domain inhibitor (+)-JQ1, Purity ≥98%
|
|
| X24-05-ZQ406 |
Epigenetic reader domain inhibitor (+)-JQ1 PA, Purity ≥98%
|
|
| X24-05-ZQ407 |
Epigenetic reader domain inhibitor (-)-JQ1, Purity ≥98%
|
|
| X24-05-ZQ408 |
Epigenetic reader domain inhibitor (E)-ZL0420, Purity ≥98%
|
|
| X24-05-ZQ409 |
Epigenetic reader domain inhibitor (Rac)-BAY1238097, Purity ≥98%
|
|
| X24-05-ZQ410 |
Epigenetic reader domain inhibitor A-485, Purity ≥98%
|
|
| X24-05-ZQ411 |
Epigenetic reader domain inhibitor A1874, Purity ≥98%
|
|
| X24-05-ZQ412 |
Epigenetic reader domain inhibitor ABBV-744, Purity ≥98%
|
|
| X24-05-ZQ413 |
Epigenetic reader domain inhibitor Alobresib, Purity ≥98%
|
|
| X24-05-ZQ415 |
Epigenetic reader domain inhibitor Apabetalone, Purity ≥98%
|
|
| X24-05-ZQ416 |
Epigenetic reader domain inhibitor ARV-825, Purity ≥98%
|
|
| X24-05-ZQ417 |
AZD5153 6-hydroxy-2-naphthoic acid, Purity ≥98%
|
|
| X24-05-ZQ418 |
Epigenetic reader domain inhibitor BAY-299, Purity ≥98%
|
|
| X24-05-ZQ419 |
Epigenetic reader domain inhibitor BAY1238097, Purity ≥98%
|
|
| X24-05-ZQ420 |
Epigenetic reader domain inhibitor BAZ2-ICR, Purity ≥98%
|
|
| X24-05-ZQ421 |
Epigenetic reader domain inhibitor BET-BAY 002, Purity ≥98%
|
|
| X24-05-ZQ422 |
Epigenetic reader domain inhibitor BET-IN-1, Purity ≥98%
|
|
| X24-05-ZQ423 |
Epigenetic reader domain inhibitor BETd-246, Purity ≥98%
|
|
| X24-05-ZQ424 |
Epigenetic reader domain inhibitor BI-7273, Purity ≥98%
|
|
| X24-05-ZQ425 |
Epigenetic reader domain inhibitor BI-9564, Purity ≥98%
|
|
| X24-05-ZQ426 |
Epigenetic reader domain inhibitor BMS-986158, Purity ≥98%
|
|
| X24-05-ZQ427 |
Epigenetic reader domain inhibitor BRD-IN-3, Purity ≥98%
|
|
| X24-05-ZQ428 |
Epigenetic reader domain inhibitor BRD4 inhibitor-10, Purity ≥98%
|
|
| X24-05-ZQ429 |
Epigenetic reader domain inhibitor BRD7-IN-1 free base, Purity ≥98%
|
|
| X24-05-ZQ430 |
Epigenetic reader domain inhibitor Bromodomain IN-1, Purity ≥98%
|
|
| X24-05-ZQ431 |
Bromodomain inhibitor-8, Purity ≥98%
|
|
| X24-05-ZQ432 |
Epigenetic reader domain inhibitor Bromosporine, Purity ≥98%
|
|
| X24-05-ZQ433 |
Epigenetic reader domain inhibitor C646, Purity ≥98%
|
|
| X24-05-ZQ434 |
Epigenetic reader domain inhibitor CD235, Purity ≥98%
|
|
| X24-05-ZQ435 |
Epigenetic reader domain inhibitor CeMMEC13, Purity ≥98%
|
|
| X24-05-ZQ436 |
Epigenetic reader domain inhibitor CF53, Purity ≥98%
|
|
| X24-05-ZQ437 |
Epigenetic reader domain inhibitor CPI 0610, Purity ≥98%
|
|
| X24-05-ZQ438 |
Epigenetic reader domain inhibitor CPI-0610 carboxylic acid, Purity ≥98%
|
|
| X24-05-ZQ439 |
Epigenetic reader domain inhibitor CPI-203, Purity ≥98%
|
|
| X24-05-ZQ440 |
Epigenetic reader domain inhibitor CPI-637, Purity ≥98%
|
|
| X24-05-ZQ441 |
Epigenetic reader domain inhibitor dBET1, Purity ≥98%
|
|
| X24-05-ZQ442 |
Epigenetic reader domain inhibitor dBET57, Purity ≥98%
|
|
| X24-05-ZQ443 |
Epigenetic reader domain inhibitor E-7386, Purity ≥98%
|
|
| X24-05-ZQ444 |
Epigenetic reader domain inhibitor EML 425, Purity ≥98%
|
|
| X24-05-ZQ445 |
Epigenetic reader domain inhibitor GNE-207, Purity ≥98%
|
|
